Specify a stock or a cryptocurrency in the search bar to get a summary
Urologix Inc
ULGXUrologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota. Address: 14405 21st Avenue North, Minneapolis, MN, United States, 55447
Analytics
WallStreet Target Price
1.5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ULGX
Dividend Analytics ULGX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ULGX
Stock Valuation ULGX
Financials ULGX
Results | 2019 | Dynamics |